The molecular structure of the TLR3 extracellular domain

Abstract

Toll-like receptors (TLRs), type I integral membrane receptors, recognize pathogen associated molecular patterns (PAMPs). PAMP recognition occurs via the N-terminal ectodomain (ECD) which initiates an inflammatory response that is mediated by the C-terminal cytosolic signaling domain. To understand the molecular basis of PAMP recognition, we have begun to define TLR—ECD structurally. We have solved the structure of TLR3-ECD, which recognizes dsRNA, a PAMP associated with viral pathogens. TLR3-ECD is a horseshoe-shaped solenoid composed of 23 leucine-rich repeats (LRRs). The regular LRR surface is disrupted by two insertions at LRR12 and LRR20 and 11 N-linked carbohydrates. Of note, one side of the ECD is carbohydrate-free and could form an interaction interface. We have shown that TLR3-ECD binds directly to pI:pC, a synthetic dsRNA ligand, but not to p(dI):p(dC). Without a TLR3—dsRNA complex structure, we can only speculate how ligand binds. Analysis of the unliganded structure reveals two patches of basic residues and two binding sites for phosphate backbone mimics, sulfate ions, that may be capable of recognizing ligand. Mutational and co-crystallization studies are currently underway to determine how TLR3 binds its ligand at the molecular level.

Keywords

Toll-like receptors innate immunity protein structure

References

Takeda K. , Akira S. Toll-like receptors in innate immunity. Int Immunol 2005; 17: 1—14.

Pancer Z. , Cooper MD The evolution of adaptive immunity. Annu Rev Immunol 2006; 24: 497—518.

Fluhr R. , Kaplan-Levy RN. Plant disease resistance: commonality and novelty in multicellular innate immunity. Curr Top Microbiol Immunol 2002; 270: 23—46.

Akira S. , Uematsu S. , Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783—801.

Beg AA Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses. Trends Immunol 2002; 23: 509—512.

Beutler B. , Rietschel ET Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 2003; 3: 169—176.

Latz E. , Schoenemeyer A. , Visintin A. et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 2004; 5: 190—198.

de Bouteiller O. , Merck E. , Hasan UA et al. Recognition of double-stranded RNA by human Toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pH. J Biol Chem 2005; 280: 38133—38145.

Matsumoto M. , Funami K. , Tanabe M. et al. Subcellular localization of Toll-like receptor 3 in human dendritic cells. J Immunol 2003; 171: 3154—3162.

10.

Matsumoto M. , Kikkawa S. , Kohase M. , Miyake K. , Seya T. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling . Biochem Biophys Res Commun 2002; 293: 1364—1369.

11.

O'Neill LA How Toll-like receptors signal: what we know and what we don't know. Curr Opin Immunol 2006; 18: 3—9.

12.

Bell JK , Botos I. , Hall PR et al. The molecular structure of the Toll-like receptor 3 ligand-binding domain. Proc Natl Acad Sci USA 2005; 102: 10976—10980.

13.

Kajava AV , Kobe B. Assessment of the ability to model proteins with leucine-rich repeats in light of the latest structural information. Protein Sci 2002; 11: 1082—1090.

14.

He XL , Bazan JF , McDermott G. et al. Structure of the Nogo receptor ectodomain: a recognition module implicated in myelin inhibition. Neuron 2003 ; 38: 177—185.

15.

Alexopoulou L. , Holt AC , Medzhitov R. , Flavell RA Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001; 413: 732—738.

16.

Kariko K. , Bhuyan P. , Capodici J. , Weissman D. Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through Toll-like receptor 3. J Immunol 2004; 172: 6545—6549.

17.

Kariko K. , Ni H. , Capodici J. , Lamphier M. , Weissman D. mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 2004; 279: 12542—12550.

18.

Takeda K. , Kaisho T. , Akira S. Toll-like receptors. Annu Rev Immunol 2003 ; 21: 335—376.